Lumicks
LUMICKS is the world-leader in Dynamic Single-Molecule analysis (“DSM”) and is focused on establishing this breakthrough approach as a standard analytical method in molecular biology and drug discovery. We achieve this through the increasingly rapid adoption by scientific KOLs and publications by early adopters, as well as through our growing pharma customer base. With a complementary and growing product line, LUMICKS is well positioned to capitalize on the market opportunity for this technology across the academic and pharma segments.